Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1815)	10/16/2000 10:08:23 PM
From: Bob L	Respond to of 2001

The only way that begins to make any sense to me is if I think of reader inconsistency as noise. As the noise level increases, I can't see treatment differences because I can't see anything at all. Starts looking increasingly random.

To: scaram(o)uche who wrote (1815)	10/17/2000 11:33:04 AM
From: Biomaven	Read Replies (2) \| Respond to of 2001

this appears to be alteration with guidance and intent It does seem to be stretching coincidence too far that this happened by chance. The most benign explanation I can think of is that there are recognizably different patterns of scarring in the treatment vs. placebo MRI's and the reader (who was supposedly blinded) was consistently responding to those differences. Note that the reader might still not know which pattern went with the treated patients and which with the placebos. Of course there are considerably less benign explanations at well, all the way up to outright fraud. Personally I think the stock is too cheap at these levels, and patient buyers with strong stomachs will likely be rewarded. Peter